Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/33985
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorLEMOS, F. S.
dc.contributor.authorPEREIRA, J. X.
dc.contributor.authorCARVALHO, V. F.
dc.contributor.authorBERNARDES, E. S.
dc.contributor.authorCHAMMAS, R.
dc.contributor.authorPEREIRA, T. M.
dc.contributor.authorCARVALHO, R. S.
dc.contributor.authorLUISETTO, R.
dc.contributor.authorEL-CHEIKH, M. C.
dc.contributor.authorCALIL-ELIAS, S.
dc.contributor.authorOLIVEIRA, F. L.
dc.date.accessioned2019-11-06T18:46:41Z-
dc.date.available2019-11-06T18:46:41Z-
dc.date.issued2019
dc.identifier.citationSCIENTIFIC REPORTS, v.9, article ID 14620, 15p, 2019
dc.identifier.issn2045-2322
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/33985-
dc.description.abstractGalectin-3 (Gal-3) controls intercellular and cell-extracellular matrix interactions during immunological responses. In chronic inflammation, Gal-3 is associated with fibrotic events, regulates B cell differentiation and delays lupus progression. Gal-3 deficient mice (Lgals3(-/-)) have intense germinal center formation and atypical plasma cell generation correlated to high levels IgG, IgE, and IgA. Here, we used pristane (2,6,10,14-tetramethylpentadecane) to induce lupus-like syndrome in Lgals3(-/-) and Lgals3(+/+) BALB/c mice. Mesentery and peritoneal cells were monitored because promptly react to pristane injected in the peritoneal cavity. For the first time, mesenteric tissues have been associated to the pathogenesis of experimental lupus-like syndrome. In Lgals3(+/+ )pristane-induced mice, mesentery was hallmarked by intense fibrogranulomatous reaction restricted to submesothelial regions and organized niches containing macrophages and B lymphocytes and plasma cells. In contrast, Lgals3(-/-) pristane-treated mice had diffuse mesenteric fibrosis affecting submesothelium and peripheral tissues, atypical M1/M2 macrophage polarization and significant DLL1(+) cells expansion, suggesting possible involvement of Notch/Delta pathways in the disease. Early inflammatory reaction to pristane was characterized by significant disturbances on monocyte recruitment, macrophage differentiation and dendritic cell (DC) responses in the peritoneal cavity of pristane-induced Lgals3(-/-) mice. A correlative analysis showed that mesenteric damages in the absence of Gal-3 were directly associated with severe portal inflammation and hepatitis. In conclusion, it has suggested that Gal-3 orchestrates histological organization in the mesentery and prevents lupoid hepatitis in experimental lupus-like syndrome by controlling macrophage polarization, Notch signaling pathways and DC differentiation in mesenteric structures.eng
dc.language.isoeng
dc.publisherNATURE PUBLISHING GROUPeng
dc.relation.ispartofScientific Reports
dc.rightsopenAccesseng
dc.subject.othersubmesothelial stromal cellseng
dc.subject.otherbalb/c miceeng
dc.subject.otherdifferentiationeng
dc.subject.otheractivationeng
dc.subject.otherinterferoneng
dc.subject.otherexpressioneng
dc.subject.otherautoimmuneeng
dc.subject.othermodeleng
dc.titleGalectin-3 orchestrates the histology of mesentery and protects liver during lupus-like syndrome induced by pristaneeng
dc.typearticleeng
dc.rights.holderCopyright NATURE PUBLISHING GROUPeng
dc.identifier.doi10.1038/s41598-019-50564-8
dc.identifier.pmid31601823
dc.subject.wosMultidisciplinary Scienceseng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalLEMOS, F. S.:Univ Fed Fluminense, Fac Farm, Programa Posgrad Ciencias Aplicadas Prod Saude PP, Niteroi, RJ, Brazil
hcfmusp.author.externalPEREIRA, J. X.:Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil
hcfmusp.author.externalCARVALHO, V. F.:Fundacao Oswaldo Cruz, Lab Inflamacao, Rio De Janeiro, Brazil; Inst Nacl Ciencia & Tecnol Neuroimunomodulacao IN, Rio De Janeiro, Brazil
hcfmusp.author.externalBERNARDES, E. S.:IPEN, Ctr Radiofarm, Sao Paulo, SP, Brazil
hcfmusp.author.externalPEREIRA, T. M.:Univ Fed Rio de Janeiro, UFRJ, Fac Farm, Lab Alvos Mol,Dept Biotecnol Farmaceut, Rio De Janeiro, Brazil
hcfmusp.author.externalCARVALHO, R. S.:Univ Fed Rio de Janeiro, UFRJ, Fac Farm, Lab Alvos Mol,Dept Biotecnol Farmaceut, Rio De Janeiro, Brazil
hcfmusp.author.externalLUISETTO, R.:Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy
hcfmusp.author.externalEL-CHEIKH, M. C.:Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil
hcfmusp.author.externalCALIL-ELIAS, S.:Univ Fed Fluminense, Fac Farm, Programa Posgrad Ciencias Aplicadas Prod Saude PP, Niteroi, RJ, Brazil
hcfmusp.author.externalOLIVEIRA, F. L.:Univ Fed Fluminense, Fac Farm, Programa Posgrad Ciencias Aplicadas Prod Saude PP, Niteroi, RJ, Brazil; Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy
hcfmusp.description.articlenumber14620
hcfmusp.description.volume9
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000489555900014
hcfmusp.origem.id2-s2.0-85073109303
hcfmusp.publisher.cityLONDONeng
hcfmusp.publisher.countryENGLANDeng
hcfmusp.relation.referenceAcosta-Rodriguez EV, 2004, J IMMUNOL, V172, P493, DOI 10.4049/jimmunol.172.1.493eng
hcfmusp.relation.referenceBennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553eng
hcfmusp.relation.referenceBosisio D, 2017, J AUTOIMMUNeng
hcfmusp.relation.referenceBrand C, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0133-9eng
hcfmusp.relation.referenceBrand C, 2012, HISTOL HISTOPATHOL, V27, P1109, DOI 10.14670/HH-27.1109eng
hcfmusp.relation.referenceChen HY, 2010, INT J EXP PATHOL, V91, P460, DOI 10.1111/j.1365-2613.2010.00725.xeng
hcfmusp.relation.referenceChen SC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040565eng
hcfmusp.relation.referenceChen Y. T., 2014, J AM SOC NEPHROLeng
hcfmusp.relation.referenceCoffey JC, 2016, LANCET GASTROENTEROL, V1, P238, DOI 10.1016/S2468-1253(16)30026-7eng
hcfmusp.relation.referenceColnot C, 1998, IMMUNOLOGY, V94, P290, DOI 10.1046/j.1365-2567.1998.00517.xeng
hcfmusp.relation.referenceDAVILA RM, 1993, AM J PATHOL, V142, P547eng
hcfmusp.relation.referencede Oliveira FL, 2015, EXP BIOL MED, V240, P1019, DOI 10.1177/1535370215593826eng
hcfmusp.relation.referencede Oliveira FL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21409-7eng
hcfmusp.relation.referencede Oliveira FL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005137eng
hcfmusp.relation.referenceDeng Y, 2017, CURR RHEUMATOL REP, V19, DOI 10.1007/s11926-017-0695-zeng
hcfmusp.relation.referencedo Amaral RJFC, 2014, CELLS TISSUES ORGANS, V200, P118, DOI 10.1159/000377624eng
hcfmusp.relation.referencedoAmaral R. J. F. C., 2017, CELLS TISSUES ORGANSeng
hcfmusp.relation.referenceFermin ML, 2016, MOL IMMUNOL, V76, P22, DOI 10.1016/j.molimm.2016.06.005eng
hcfmusp.relation.referenceFreitas E. C., 2017, CLIN RHEUMATOLeng
hcfmusp.relation.referenceBeccaria CG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04063-5eng
hcfmusp.relation.referenceGado K, 2001, HAEMATOLOGICA, V86, P227eng
hcfmusp.relation.referenceHenderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103eng
hcfmusp.relation.referenceHenderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726eng
hcfmusp.relation.referenceHsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9eng
hcfmusp.relation.referenceHu H., 2017, CLIN EXP IMMUNOLeng
hcfmusp.relation.referenceJung JH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002818eng
hcfmusp.relation.referenceKoca SS, 2014, CLIN RHEUMATOL, V33, P215, DOI 10.1007/s10067-013-2346-8eng
hcfmusp.relation.referenceLee PY, 2008, J IMMUNOL, V180, P5101, DOI 10.4049/jimmunol.180.7.5101eng
hcfmusp.relation.referenceLee PY, 2009, AM J PATHOL, V175, P2023, DOI 10.2353/ajpath.2009.090328eng
hcfmusp.relation.referenceLi S., 2013, J CLIN CELL IMMUNOL, V4eng
hcfmusp.relation.referenceLisi L, 2017, NEUROSCI LETT, V645, P106, DOI 10.1016/j.neulet.2017.02.076eng
hcfmusp.relation.referenceMacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650eng
hcfmusp.relation.referenceMiranda K., 2018, INT J OBES LONDeng
hcfmusp.relation.referenceNacionales DC, 2006, AM J PATHOL, V168, P1227, DOI 10.2353/ajpath.2006.050125eng
hcfmusp.relation.referenceNewlaczyl AU, 2011, CANCER LETT, V313, P123, DOI 10.1016/j.canlet.2011.09.003eng
hcfmusp.relation.referenceNielsen C. T, 2015, LUPUSeng
hcfmusp.relation.referenceOliveira FL, 2007, J LEUKOCYTE BIOL, V82, P300, DOI 10.1189/jlb.1206747eng
hcfmusp.relation.referenceOliveira F. L., 2015, CELL TISSUE RESeng
hcfmusp.relation.referenceOliveira FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019216eng
hcfmusp.relation.referencePagie S, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-017-0214-xeng
hcfmusp.relation.referencePerry D, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/271694eng
hcfmusp.relation.referencePeters T, 2011, AM J PHYSIOL-RENAL, V300, pF283, DOI 10.1152/ajprenal.00328.2010eng
hcfmusp.relation.referenceRabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536eng
hcfmusp.relation.referenceRawlings DJ, 2017, NAT REV IMMUNOL, V17, P421, DOI 10.1038/nri.2017.24eng
hcfmusp.relation.referenceRichards HB, 2000, CURR TOP MICROBIOL, V252, P201eng
hcfmusp.relation.referenceSaccon F, 2017, AUTOIMMUN REV, V16, P34, DOI 10.1016/j.autrev.2016.09.023eng
hcfmusp.relation.referenceSantos MA, 2007, P NATL ACAD SCI USA, V104, P15454, DOI 10.1073/pnas.0702891104eng
hcfmusp.relation.referenceSATOH M, 1995, P NATL ACAD SCI USA, V92, P10934, DOI 10.1073/pnas.92.24.10934eng
hcfmusp.relation.referenceSATOH M, 1994, J EXP MED, V180, P2341, DOI 10.1084/jem.180.6.2341eng
hcfmusp.relation.referenceShapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429eng
hcfmusp.relation.referenceStepan S, 2016, CLIN IMMUNOL, V172, P65, DOI 10.1016/j.clim.2016.07.007eng
hcfmusp.relation.referenceWu Z, 2018, AM J PHYSIOL-GASTR L, V315, pG659, DOI 10.1152/ajpgi.00079.2018eng
dc.description.indexMEDLINEeng
hcfmusp.citation.scopus6-
hcfmusp.scopus.lastupdate2024-03-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MDR
Departamento de Radiologia - FM/MDR

Artigos e Materiais de Revistas Científicas - LIM/24
LIM/24 - Laboratório de Oncologia Experimental

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_LEMOS_Galectin3_orchestrates_the_histology_of_mesentery_and_protects_2019.PDFpublishedVersion (English)3.76 MBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.